Trials / Completed
CompletedNCT00374647
Study to Evaluate Safety and Efficacy of Early Calcineurin Inhibitor Withdrawal in Primary Renal Allografts
Open Label Randomized Single Study to Evaluate the Safety & Efficacy of Early CNI Withdrawal in Recipients of Primary Renal Allografts Maintained Long-Term on Mycophenolate Mofetil; MMF (CellCept) and Sirolimus (Rapamune)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- University of Cincinnati · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the safety and efficacy of early corticosteroid withdrawal and simultaneous calcineurin inhibitor withdrawal in recipients of primary renal allografts maintained long-term on MMF and sirolimus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | mycophenolate mofetil | |
| DRUG | sirolimus |
Timeline
- Start date
- 2005-03-01
- Primary completion
- 2007-12-01
- Completion
- 2007-12-01
- First posted
- 2006-09-11
- Last updated
- 2021-07-15
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00374647. Inclusion in this directory is not an endorsement.